Clinical Trial Update: A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial completed to determine whether stopping anti-HIV therapy can be done without causing viral resistance and to characterize how the drug …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED